publication venue for
- A technique for approximating transition rates from published survival analyses. 17:12. 2019
- Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis. 12:18-18. 2014
- The impact of incorporating Bayesian network meta-analysis in cost-effectiveness analysis - a case study of pharmacotherapies for moderate to severe COPD. 12:8-8. 2014
- Surrogate outcomes: experiences at the Common Drug Review. 11:31-31. 2013
- Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada. 8:14-14. 2010
- Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis. 7:20-20. 2009
- Is cost-effectiveness analysis preferred to severity of disease as the main guiding principle in priority setting in resource poor settings? The case of Uganda.. 2:1-1. 2004